Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Composition : Levosulpiride (75mg) + Rabeprazole (20mg)
Dosage Form : Capsule
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹220/-
Ribziff L Capsule is a combination medicine designed to address gastroesophageal reflux disease (GERD), acid reflux, and functional dyspepsia. The formulation combines Levosulpiride, a prokinetic agent that enhances gastrointestinal motility, with Rabeprazole, a proton pump inhibitor (PPI) that reduces stomach acid production. Together, they provide comprehensive relief by alleviating symptoms such as heartburn, bloating, and nausea while promoting faster gastric emptying.
Levosulpiride works by modulating dopamine receptors in the gut, improving gastrointestinal movement and reducing acid regurgitation. Rabeprazole inhibits the final step in gastric acid secretion, creating a long-lasting reduction in stomach acidity and fostering the healing of ulcers and inflamed esophageal linings. This synergistic action makes Ribziff L a reliable solution for patients suffering from GERD and related conditions.
The capsule form offers convenience and precise dosing, ensuring optimal therapeutic benefits. Ribziff L is best taken before meals to enhance its efficacy.
Common side effects include dizziness, headache, nausea, diarrhea, or constipation. Rarely, it may cause allergic reactions, fatigue, or changes in liver enzymes.
Indicated for gastroesophageal reflux disease (GERD), functional dyspepsia, and related acid reflux conditions.
Use only as prescribed by a healthcare professional. Avoid in cases of known allergies to PPIs or prokinetic agents. Do not discontinue abruptly without consulting your doctor.
Composition : Levosulpiride (75mg) + Esomeprazole (40mg)
Composition : Levofloxacin (500mg)
Composition : Levosulpiride (75mg) + Pantoprazole (40mg)
Composition : Levofloxacin (750mg)
Composition : Omeprazole (20mg)
Composition : Pantoprazole (40mg) + Itopride (150mg)